Mei Xue1, Wei Chen2, Xu Li3. 1. Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, 710061, People's Republic of China. 2. Clinical Laboratory, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, People's Republic of China. 3. Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, 710061, People's Republic of China. lixuxjtu2014@126.com.
Abstract
BACKGROUND: Urothelial cancer associated 1 (UCA1) is a long noncoding RNA (lncRNA) which has gained more attention in recent years due to its aberrant expression in embryogenesis and a broad range of cancer tissues and cells. Importantly, multiple studies have shown that UCA1 plays oncogenic roles in tumor growth and metastasis, and it may act as a potential biomarker and therapeutic target for human cancers. However, the molecular mechanism of UCA1 in cancer initiation, progression and metastasis remains incompletely understood. Thus, gaining a better understanding of the functional mechanism of UCA1 in cancer onset and progression is of the utmost significance for evaluating the potential application of UCA1. RESULTS AND DISCUSSION: In this review, we discuss UCA1 expression profiling, isoform, expression regulation, biological role and mechanism for UCA1 tumor-promoting effect. We further discuss the potential clinical application of UCA1 as a promising diagnostic biomarker or therapeutic target for human cancers. CONCLUSION: UCA1 functions as an oncogenic lncRNA in several malignancies, and it might become a potential biomarker or therapeutic target for human cancers.
BACKGROUND:Urothelial cancer associated 1 (UCA1) is a long noncoding RNA (lncRNA) which has gained more attention in recent years due to its aberrant expression in embryogenesis and a broad range of cancer tissues and cells. Importantly, multiple studies have shown that UCA1 plays oncogenic roles in tumor growth and metastasis, and it may act as a potential biomarker and therapeutic target for humancancers. However, the molecular mechanism of UCA1 in cancer initiation, progression and metastasis remains incompletely understood. Thus, gaining a better understanding of the functional mechanism of UCA1 in cancer onset and progression is of the utmost significance for evaluating the potential application of UCA1. RESULTS AND DISCUSSION: In this review, we discuss UCA1 expression profiling, isoform, expression regulation, biological role and mechanism for UCA1tumor-promoting effect. We further discuss the potential clinical application of UCA1 as a promising diagnostic biomarker or therapeutic target for humancancers. CONCLUSION:UCA1 functions as an oncogenic lncRNA in several malignancies, and it might become a potential biomarker or therapeutic target for humancancers.
Entities:
Keywords:
Cancer; Chemoresistance; Long noncoding RNA; Metastasis; UCA1
Authors: Subbareddy Maddika; Sudharsana Rao Ande; Soumya Panigrahi; Ted Paranjothy; Kazimierz Weglarczyk; Anne Zuse; Mehdi Eshraghi; Kamala D Manda; Emilia Wiechec; Marek Los Journal: Drug Resist Updat Date: 2007-02-14 Impact factor: 18.500
Authors: Chun Hong Xiao; Hai Zhong Yu; Chun Yan Guo; Zhi Mei Wu; Hong Yan Cao; Wei Bing Li; Jian Fen Yuan Journal: Oncol Lett Date: 2018-08-03 Impact factor: 2.967
Authors: Mateus S V Mota; William P Jackson; Sarah K Bailey; Praveen Vayalil; Aimee Landar; Jack W Rostas; Madhuri S Mulekar; Rajeev S Samant; Lalita A Shevde Journal: Carcinogenesis Date: 2018-09-21 Impact factor: 4.944